SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: PAL who wrote (4323)5/18/1998 3:43:00 PM
From: Robert L. Ray  Read Replies (1) of 6136
 
To All,

Well I added more to my position on the weakness today so AGPH is now my largest holding. Man is this thing a bargain. It's being penalized for being a one drug company when most biotechs are no drug companies. Of course everyone one here knows that, but it bears repeating. People are afraid of competition lurking out there somewhere. Well for sure Viracept is not subject to any more potential competition than any other number 1 in it's class drug. Another way I look at it is compared to XYZ Hi-Tech company with a top selling product the solidity of market share for Viracept is most excellent. If it goes down another point I'm selling something else and buying more AGPH. It's the best bargain with tremendous growth potential I see in an overpriced market by a mile.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext